TOWA PHARMACEUTICAL CO., LTD.
東和薬品株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4553
FY2025 · 2026-03-31
| Gross margin | 36.2% |
| Operating margin | 8.4% |
| Net margin | 1.9% |
| Return on equity | 3.3% |
| Return on assets | 1.1% |
| Revenue growth (YoY) | 5.4% |
| EPS (basic) | ¥106.66 |
| EPS growth (YoY) | -72.3% |
| Current ratio | 2.76x |
| Equity ratio | 33.4% |
| Book value / share | ¥3,617.95 |
| Free cash flow | 8,152 M |